The Big Money Behind Kentucky AG Daniel Cameron's Bizarre Psychedelic Drug Crusade
YASS KING
The inside story about a state commission that wants to spend $42 million on a controversial psychedelic drug to treat opioid addiction—and the complicated reasons why.
